Clin2
NCT07275424Possibly a fitRecruiting

Testing a drug to improve physical function in older adults

Aging, Healthy

This study tests a drug called elamipretide to see if it can improve physical function in older adults with lower mitochondrial health. It may help you keep your energy and independence as you age.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
65 years to 80 years
Study type
Interventional

Who can take part

  • You are between 65 and 80 years old
  • You have a lower level of fitness based on a breathing test (VO2 peak)
  • You can walk and do daily tasks without help
  • You are not currently exercising regularly or doing physical hobbies like dance or yoga
  • You are willing to give yourself injections (or have a helper)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07699380Recruiting· Phase 2
Metabolic study to improve insulin sensitivity in type 1 diabetes

This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.

Seattle, Washington
NCT06645847Recruiting
Ketone drink for walking and strength in older adults

This study tests whether a special ketone drink can help older adults who are starting to feel frail (slower walking, less energy). You would be assigned to one of several groups, and researchers will check if the drink improves your strength and daily function.

Novato, California
NCT06554717Recruiting· Phase 2
Tesamorelin and exercise for physical function in HIV

This study tests whether adding tesamorelin to an exercise program helps older adults with HIV improve their physical function and reduce belly fat. It is designed for people who are mostly sedentary and show early signs of frailty.

Aurora, Colorado
NCT06907329Recruiting
NMN supplement trial for middle-aged adults with metabolic issues

This trial tests whether a sustained-release nicotinamide mononucleotide (NMN) supplement can improve immune aging and metabolism in people aged 50-70 who are overweight or have fatty liver, pre-diabetes, or mild type 2 diabetes.

Shanghai
NCT07144527Recruiting
NMN supplement for exercise in healthy older adults

This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.

Beverly Hills, California
NCT07072195Recruiting· Phase 2
A study of AMC6156 for people with muscle loss

This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.

Seongnam-si, Gyeonggi-do

Hear when a new Aging, Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.